Kempharm, Inc (KMPH)

Trade KMPH now with
3/20/2018 7:33:43 AM KemPharm Announces Positive Topline Results From KP415 Pharmacokinetic Study In Children And Adolescents With ADHD
3/5/2018 9:22:13 AM New Drugs Approved In February
1/23/2018 7:35:33 AM KemPharm Receives Patent Grant For KP606, A Prodrug Of Oxycodone
1/8/2018 7:38:34 AM KemPharm Initiates Pivotal Efficacy Trial Of KP415
11/16/2017 7:30:58 AM KemPharm Completes End-of-Phase 2 Meeting On KP415 With FDA
10/4/2017 7:34:28 AM KemPharm, Genco To Develop Prodrug-Based Therapy For Rare Pediatric Indications Of Tourette’s Syndrome With ADHD
9/20/2017 7:33:53 AM KemPharm Files IND For KP484 For Treatment Of ADHD, An Investigational Prodrug Of Methylphenidate